Basic science research on erectile dysfunction (ED) has mainly focused on the mechanisms of corpus cavernosal smooth muscle relaxation. Current pharmacotherapy for ED takes advantage of the biochemical and physiological mechanisms that relax erectile tissue to achieve erectile function suf®cient for normal sexual activity. Animal models have enabled researchers to carefully study smooth muscle physiology and pharmacology in order to develop speci®c medications for the treatment of sexual dysfunction.
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In order to understand the various mechanisms which govern corpora cavernosal smooth muscle tone and erectile function, one must investigate a number of variables in a systematic and scienti®c manner. The ®rst animal model that was used to study the pharmacological effects of different agents on erection was the cat. 1 In this model, catheters are inserted into the external jugular vein for intravenous administration of drugs and into the carotid artery for the measurement of systemic arterial pressure (Figure 1) . A vertical, circumcision-like incision is made to expose the two ventral corpora cavernosa and the dorsal corpus spongiosum. 2 A 30-gauge needle is placed into the right corpus cavernosum to permit administration of drugs into the penis. A 25-gauge needle is placed midway into the left corpus cavernosum for the continuous measurement of intracavernosal pressure (mmHg) (Figure 1) . In experiments in which the transurethral administration of a vasoactive agent is employed, drugs are introduced into the urethra via a 20-gauge Jelco i.v. catheter (Figure 1 ). Systemic and intracavernosal pressures (mmHg) are measured with a polygraph, and mean pressures are obtained by electronic averaging (Figure 1 ). Penile length (mm) is measured with a ruler. After dose ± response curves for pharmacological agents have been attained, a standard control combination of papaverine (1.65 mg), prostaglandin E 1 (PGE 1 ) (0.5 mg), and phentolamine (25 mg) is prepared and injected intracavernosally at the end of each experiment to serve as a control comparison. In this model, one can measure changes in intracavernosal pressure and penile length, total duration of erectile response, and alterations in systemic arterial blood pressure (Table 1 ). The feline model is an excellent animal species to examine the physiology of penile erection because both the cGMP and cAMP second messenger systems are functional in this species and are very similar to the erectile mechanisms operational in humans. Other signi®cant advantages of this animal model are the relatively large size of the penis and two corpora cavernosa which communicate as in the human penis. Hence, one can place a needle in one corpora for measurement of intracavernosal pressures, and one can concurrently inject pharmacological agents into the other corpora and observe instantaneous changes in pressure measurements.
Another well-recognized and widely accepted model to study the physiology of human erections is the primate model. 3 The basic hemodynamics of erection were established in this model, and our overall understanding of the erectile process in humans has been directly extrapolated from studies performed on primates. 4 The major advantages of the primate model are the large size of the penis and overall comparable penile structural anatomy of the penis when compared with other laboratory animals. However, there are some obstacles with the use of this species. Problems with the scarcity of animals and ®nancial restraints limit the number of routine erection studies that can be performed with the primate.
The canine model has been extremely useful when studying the pharmacokinetics of pharmacological agents and certain histological conditions. 5, 6 It has become the standard model for pharmaceutical evaluation of the safety and toxicology of cardiovascular agents. However, the ®rst major disadvantage with the dog is the presence of two separate corpora cavernosa which do not communicate. Researchers must place two needles into the same corpora: one to measure intracavernosal pressure and the other for drug delivery. Second, there is signi®cant inter-dog variability. Third, the cAMP system is not a predominate second messenger system in canine erectile physiology. Therefore, the dog model is an excellent model for the study of drug pharmacokinetics, but in other areas it is dif®cult to apply scienti®c data to the human condition.
In conclusion, each animal model of penile erection has contributed something to our understanding about the physiology and pharmacology of human erections. No single animal model will be completely satisfactory, therefore we have to recognize each of their strengths and limitations. The cat and primate are unique from most other animal models of penile erection in that they both possess coupled cAMP and cGMP second messenger systems. The larger size of the penis in cats, dogs, and primates allows for more accurate and reproducible hemodynamic measurements. One can anticipate that in the decades to come animal erection models will likely become more a part of the drug development process, as scientists search for more selective pharmaceutical vasoactive agents with improved ef®cacy and fewer side effects. 
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